Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanism

Frontiers in Cell and Developmental Biology

Volumn 3, Issue JUN, 2015, Pages

  Gole, Boris ^a   Wiesmüller, Lisa ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Apoptosis; Error prone DNA repair; Infant acute leukemia; MLL breakpoint cluster region; Replication stress; Therapy related leukemia

Indexed keywords

EID: 84942365600     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2015.00041     Document Type: Review

References (123)

1. Abdulwahab, A., Sykes, J., Kamel-Reid, S., Chang, H., and Brandwein, J. M. (2012). Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis. Cancer 118, 3962-3967. doi: 10.1002/cncr.26735
2. Al-Sudairy, R., Al-Nasser, A., Alsultan, A., Al Ahmari, A., Abosoudah, I., Al-Hayek, R., et al. (2014). Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia in Saudi Arabia: a multi-institutional retrospective national collaborative study. Pediatr. Blood Cancer 61, 74-80. doi: 10.1002/pbc.24584
3. Aplan, P. D., Chervinsky, D. S., Stanulla, M., and Burhans, W. C. (1996). Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87, 2649-2658
4. Atkinson, J., and McGlynn, P. (2009). Replication fork reversal and the maintenance of genome stability. Nucleic Acids Res. 37, 3475-3492. doi: 10.1093/nar/gkp244
5. Berquist, B. R., and Wilson, D. M. III. (2012). Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. Cancer Lett. 327, 61-72. doi: 10.1016/j.canlet.2012.02.001
6. Betti, C. J., Villalobos, M. J., Diaz, M. O., and Vaughan, A. T. (2001). Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system. Cancer Res. 61, 4550-4555
7. Betti, C. J., Villalobos, M. J., Diaz, M. O., and Vaughan, A. T. (2003). Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division. Cancer Res. 63, 1377-1381
8. Betti, C. J., Villalobos, M. J., Jiang, Q., Cline, E., Diaz, M. O., Loredo, G., et al. (2005). Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity. Leukemia 19, 2289-2295. doi: 10.1038/sj.leu.2403966
9. Boehden, G. S., Restle, A., Marschalek, R., Stocking, C., and Wiesmüller, L. (2004). Recombination at chromosomal sequences involved in leukaemogenic rearrangements is differentially regulated by p53. Carcinogenesis 25, 1305-1313. doi: 10.1093/carcin/bgh092
10. Bolton, J. L., and Thatcher, G. R. (2008). Potential mechanisms of estrogen quinone carcinogenesis. Chem. Res. Toxicol. 21, 93-101. doi: 10.1021/tx700191p
11. Bousquet, M., Quelen, C., Rosati, R., Mansat-De Mas, V., La Starza, R., Bastard, C., et al. (2008). Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J. Exp. Med. 205, 2499-2506. doi: 10.1084/jem.20080285
12. Britton, S., Frit, P., Biard, D., Salles, B., and Calsou, P. (2009). ARTEMIS nuclease facilitates apoptotic chromatin cleavage. Cancer Res. 69, 8120-8126. doi: 10.1158/0008-5472.CAN-08-4400
13. Broeker, P. L., Super, H. G., Thirman, M. J., Pomykala, H., Yonebayashi, Y., Tanabe, S., et al. (1996). Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 87, 1912-1922
14. Bueno, C., Catalina, P., Melen, G. J., Montes, R., Sánchez, L., Ligero, G., et al. (2009). Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis 30, 1628-1637. doi: 10.1093/carcin/bgp169
15. Ceccaldi, R., Parmar, K., Mouly, E., Delord, M., Kim, J. M., Regairaz, M., et al. (2012). Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell 11, 36-49. doi: 10.1016/j.stem.2012.05.013
16. Cerveira, N., Lisboa, S., Correia, C., Bizarro, S., Santos, J., Torres, L., et al. (2012). Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution. Mol. Oncol. 6, 553-564. doi: 10.1016/j.molonc.2012.06.004
17. Chan, W. K., Kung Sutherland, M., Li, Y., Zalevsky, J., Schell, S., and Leung, W. (2012). Antibody-dependent cell-mediated cytotoxicity overcomes NK cell resistance in MLL-rearranged leukemia expressing inhibitory KIR ligands but not activating ligands. Clin. Cancer Res. 18, 6296-6305. doi: 10.1158/1078-0432.CCR-12-0668
18. Chen, Y., Kantarjian, H., Pierce, S., Faderl, S., O'Brien, S., Qiao, W., et al. (2013). Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation. Leukemia 27, 836-842. doi: 10.1038/leu.2012.319
19. Cheshier, S. H., Morrison, S. J., Liao, X., and Weissman, I. L. (1999). In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 96, 3120-3125. doi: 10.1073/pnas.96.6.3120
20. Cimino, G., Rapanotti, M. C., Biondi, A., Elia, L., Lo Coco, F., Price, C., et al. (1997). Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res. 57, 2879-2883
21. Cowell, I. G., and Austin, C. A. (2012). Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents. Int. J. Environ. Res. Public Health 9, 2075-2091. doi: 10.3390/ijerph9062075
22. Cowell, I. G., Sondka, Z., Smith, K., Lee, K. C., Manville, C. M., Sidorczuk-Lesthuruge, M., et al. (2012). Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity. Proc. Natl. Acad. Sci. U.S.A. 109, 8989-8994. doi: 10.1073/pnas.1204406109
23. Cunningham, F., Amode, M. R., Barrell, D., Beal, K., Billis, K., Brent, S., et al. (2015). Ensembl 2015. Nucleic Acids Res. 43, D662-D669. doi: 10.1093/nar/gku1010
24. Daniel, J. A., and Nussenzweig, A. (2012). Roles for histone H3K4 methyltransferase activities during immunoglobulin class-switch recombination. Biochim. Biophys. Acta 1819, 733-738. doi: 10.1016/j.bbagrm.2012.01.019
25. Debatisse, M., Le Tallec, B., Letessier, A., Dutrillaux, B., and Brison, O. (2012). Common fragile sites: mechanisms of instability revisited. Trends Genet. 28, 22-32. doi: 10.1016/j.tig.2011.10.003
26. De Braekeleer, E., Meyer, C., Douet-Guilbert, N., Basinko, A., Le Bris, M. J., Morel, F., et al. (2011). Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory. Mol. Oncol. 5, 555-563. doi: 10.1016/j.molonc.2011.08.003
27. De Braekeleer, M., Morel, F., Le Bris, M. J., Herry, A., and Douet-Guilbert, N. (2005). The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia. Anticancer Res. 25, 1931-1944
28. de la Chica, R. A., Mediano, C., Salido, M., Espinet, B., Manresa, J. M., and Solé, F. (2011). Increased MLL gene rearrangements in amniocytes from fetuses of mothers who smoke. Leuk. Res. 35, 1066-1069. doi: 10.1016/j.leukres.2011.04.010
29. Desai, A., Qing, Y., and Gerson, S. L. (2014). Exonuclease 1 is a critical mediator of survival during DNA double strand break repair in nonquiescent hematopoietic stem and progenitor cells. Stem Cells 32, 582-593. doi: 10.1002/stem.1596
30. Do, T. U., Ho, B., Shih, S. J., and Vaughan, A. (2012). Zinc Finger Nuclease induced DNA double stranded breaks and rearrangements in MLL. Mutat. Res. 740, 34-42. doi: 10.1016/j.mrfmmm.2012.12.006
31. Dong, C., and Chen, L. (2014). Second malignancies after breast cancer: the impact of adjuvant therapy. Mol. Clin. Oncol. 2, 331-336. doi: 10.3892/mco.2014.250
32. Durkin, S. G., and Glover, T. W. (2007). Chromosome fragile sites. Annu. Rev. Genet. 41, 169-192. doi: 10.1146/annurev.genet.41.042007.165900
33. Dvorak, P., Lysak, D., Vokurka, S., Michalova, K., Sarova, I., Jonasova, A., et al. (2014). The translocation t(2;11)(p21;q23) without MLL gene rearrangement-a possible marker of good prognosis in myelodysplastic syndrome patients. Hematol. Oncol. 32, 82-86. doi: 10.1002/hon.2089
34. Emerenciano, M., Koifman, S., and Pombo-de-Oliveira, M. S. (2007). Acute leukemia in early childhood. Braz. J. Med. Biol. Res. 40, 749-760. doi: 10.1590/S0100-879X2007000600002
35. Emerenciano, M., Meyer, C., Mansur, M. B., Marschalek, R., and Pombo-de-Oliveira, M. S. (2013). The distribution of MLL breakpoin ts correlates with outcome in infant acute leukaemia. Br. J. Haematol. 161, 224-236. doi: 10.1111/bjh.12250
36. Ensminger, M., Iloff, L., Ebel, C., Nikolova, T., Kaina, B., and Löbrich, M. (2014). DNA breaks and chromosomal aberrations arise when replication meets base excision repair. J. Cell Biol. 206, 29-43. doi: 10.1083/jcb.201312078
37. Ezoe, S. (2012). Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor. Int. J. Environ. Res. Public Health 9, 2444-2453. doi: 10.3390/ijerph9072444
38. Faller, B. A., Robu, V. G., and Borghaei, H. (2009). Therapy-related acute myelogenous leukemia with an 11q23/MLL translocation following adjuvant cisplatin and vinorelbine for non-small-cell lung cancer. Clin. Lung Cancer 10, 438-440. doi: 10.3816/CLC.2009.n.082
39. Felix, C. A., Lange, B. J., Hosler, M. R., Fertala, J., and Bjornsti, M. A. (1995). Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res. 55, 4287-4292
40. Fierz, B., Chatterjee, C., McGinty, R. K., Bar-Dagan, M., Raleigh, D. P., and Muir, T. W. (2011). Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction. Nat. Chem. Biol. 7, 113-119. doi: 10.1038/nchembio.501
41. Flach, J., Bakker, S. T., Mohrin, M., Conroy, P. C., Pietras, E. M., Reynaud, D., et al. (2014). Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 512, 198-202. doi: 10.1038/nature13619
42. Flynn, C. M., and Kaufman, D. S. (2007). Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood 109, 2688-2691. doi: 10.1182/blood-2006-07-021980
43. Gale, K. B., Ford, A. M., Repp, R., Borkhardt, A., Keller, C., Eden, O. B., et al. (1997). Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc. Natl. Acad. Sci. U.S.A. 94, 13950-13954. doi: 10.1073/pnas.94.25.13950
44. Glover, T. W., Berger, C., Coyle, J., and Echo, B. (1984). DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 67, 136-142. doi: 10.1007/BF00272988
45. Glukhov, S. I., Rubtsov, M. A., Alexeyevsky, D. A., Alexeevski, A. V., Razin, S. V., and Iarovaia, O. V. (2013). The broken MLL gene is frequently located outside the inherent chromosome territory in human lymphoid cells treated with DNA topoisomerase II poison etoposide. PLoS ONE 8:e75871. doi: 10.1371/journal.pone.0075871
46. Gole, B., Baumann, C., Mian, E., Ireno, C. I., and Wiesmüller, L. (2014). Endonuclease G initiates DNA rearrangements at the MLL breakpoint cluster upon replication stress. Oncogene. doi: 10.1038/onc.2014.268. [Epub ahead of print]
47. Gué, M., Sun, J. S., and Boudier, T. (2006). Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited. BMC Cancer 6:20. doi: 10.1186/1471-2407-6-20
48. Hakim, O., Resch, W., Yamane, A., Klein, I., Kieffer-Kwon, K. R., Jankovic, M., et al. (2012). DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature 484, 69-74. doi: 10.1038/nature10909
49. Hars, E. S., Lyu, Y. L., Lin, C. P., and Liu, L. F. (2006). Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia. Cancer Res. 66, 8975-8979. doi: 10.1158/0008-5472.CAN-06-1724
50. Hensel, J. P., Gillert, E., Fey, G. H., and Marschalek, R. (2001). Breakpoints of t(4;11) translocations in the human MLL and AF4 genes in ALL patients are preferentially clustered outside of high-affinity matrix attachment regions. J. Cell. Biochem. 82, 299-309. doi: 10.1002/jcb.1161
51. Hertenstein, B., Hambach, L., Bacigalupo, A., Schmitz, N., McCann, S., Slavin, S., et al. (2005). Development of leukemia in donor cells after allogenic transplantation-a survey of the European Group of Blood and Marrow Transplantation (EBMT). Haematologica 90, 969-975
52. Hess, J. L., Yu, B. D., Li, B., Hanson, R., and Korsmeyer, S. J. (1997). Defects in yolk sac hematopoiesis in Mll-null embryos. Blood 90, 1799-1806
53. Ireno, I. C., Baumann, C., Stöber, R., Hengstler, J. G., and Wiesmüller, L. (2014). Fluorescence-based recombination assay for sensitive and specific detection of genotoxic carcinogens in human cells. Arch. Toxicol. 88, 1141-1159. doi: 10.1007/s00204-014-1229-3
54. Kalinowska, M., Garncarz, W., Pietrowska, M., Garrard, W. T., and Widlak, P. (2005). Regulation of the human apoptotic DNase/RNase endonuclease G: involvement of Hsp70 and ATP. Apoptosis 10, 821-830. doi: 10.1007/s10495-005-0410-9
55. Khobta, A., Carlo-Stella, C., and Capranico, G. (2004). Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene. Cancer Res. 64, 2656-2662. doi: 10.1158/0008-5472.CAN-03-1126
56. Koontz, M. Z., Horning, S. J., Balise, R., Greenberg, P. L., Rosenberg, S. A., Hoppe, R. T., et al. (2013). Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. J. Clin. Oncol. 31, 592-598. doi: 10.1200/JCO.2012.44.5791
57. Kowarz, E., Dingermann, T., and Marschalek, R. (2012). Do non-genomically encoded fusion transcripts cause recurrent chromosomal translocations? Cancers (Basel). 4, 1036-1049. doi: 10.3390/cancers4041036
58. Kowarz, E., Merkens, J., Karas, M., Dingermann, T., and Marschalek, R. (2011). Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancer. Am. J. Blood Res. 1, 1-12
59. Kraft, D., Rall, M., Volcic, M., Metzler, E., Groo, A., Stahl, A., et al. (2015). NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells. Leukemia. doi: 10.1038/leu.2015.28. [Epub ahead of print]
60. Krawczyk, P. M., Borovski, T., Stap, J., Cijsouw, T., ten Cate, R., Medema, J. P., et al. (2012). Chromatin mobility is increased at sites of DNA double-strand breaks. J. Cell Sci. 125, 2127-2133. doi: 10.1242/jcs.089847
61. Labi, V., Erlacher, M., Krumschnabel, G., Manzl, C., Tzankov, A., Pinon, J., et al. (2010). Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev. 24, 1602-1607. doi: 10.1101/gad.1940210
62. Le, H., Singh, S., Shih, S. J., Du, N., Schnyder, S., Loredo, G. A., et al. (2009). Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding. Genes Chromosomes Cancer 48, 806-815. doi: 10.1002/gcc.20685
63. Letessier, A., Millot, G. A., Koundrioukoff, S., Lachagès, A. M., Vogt, N., Hansen, R. S., et al. (2011). Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 470, 120-123. doi: 10.1038/nature09745
64. Libura, J., Ward, M., Solecka, J., and Richardson, C. (2008). Etoposide-initiated MLL rearrangements detected at high frequency in human primitive hematopoietic stem cells with in vitro and in vivo long-term repopulating potential. Eur. J. Haematol. 81, 185-195. doi: 10.1111/j.1600-0609.2008.01103.x
65. Liu, H., Takeda, S., Kumar, R., Westergard, T. D., Brown, E. J., Pandita, T. K., et al. (2010). Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. Nature 467, 343-346. doi: 10.1038/nature09350
66. Lovett, B. D., Lo Nigro, L., Rappaport, E. F., Blair, I. A., Osheroff, N., Zheng, N., et al. (2001). Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation. Proc. Natl. Acad. Sci. U.S.A. 98, 9802-9807. doi: 10.1073/pnas.171309898
67. Macheret, M., and Halazonetis, T. D. (2015). DNA replication stress as a hallmark of cancer. Annu. Rev. Pathol. 10, 425-448. doi: 10.1146/annurev-pathol-012414-040424
68. Maddams, J., Parkin, D. M., and Darby, S. C. (2011). The cancer burden in the United Kingdom in 2007 due to radiotherapy. Int. J. Cancer 129, 2885-2893. doi: 10.1002/ijc.26240
69. Meyer, C., Hofmann, J., Burmeister, T., Gröger, D., Park, T. S., Emerenciano, M., et al. (2013). The MLL recombinome of acute leukemias in 2013. Leukemia 27, 2165-2176. doi: 10.1038/leu.2013.135
70. Meyer, C., Kowarz, E., Hofmann, J., Renneville, A., Zuna, J., Trka, J., et al. (2009). New insights to the MLL recombinome of acute leukemias. Leukemia 23, 1490-1499. doi: 10.1038/leu.2009.33
71. Meyer, C., Kowarz, E., Schneider, B., Oehm, C., Klingebiel, T., Dingermann, T., et al. (2006). Genomic DNA of leukemic patients: target for clinical diagnosis of MLL rearrangements. Biotechnol. J. 1, 656-663. doi: 10.1002/biot.200600037
72. Mirault, M. E., Boucher, P., and Tremblay, A. (2006). Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot. Am. J. Hum. Genet. 79, 779-791. doi: 10.1086/507791
73. Morton, L. M., Dores, G. M., Tucker, M. A., Kim, C. J., Onel, K., Gilbert, E. S., et al. (2013). Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood 121, 2996-3004. doi: 10.1182/blood-2012-08-448068
74. Muntean, A. G., Tan, J., Sitwala, K., Huang, Y., Bronstein, J., Connelly, J. A., et al. (2010). The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. Cancer Cell 17, 609-621. doi: 10.1016/j.ccr.2010.04.012
75. Myers, K. C., and Davies, S. M. (2009). Hematopoietic stem cell transplantation for bone marrow failure syndromes in children. Biol. Blood Marrow Transplant. 15, 279-292. doi: 10.1016/j.bbmt.2008.11.037
76. Oguchi, K., Takagi, M., Tsuchida, R., Taya, Y., Ito, E., Isoyama, K., et al. (2003). Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement. Blood 101, 3622-3627. doi: 10.1182/blood-2002-02-0570
77. Ohsato, T., Ishihara, N., Muta, T., Umeda, S., Ikeda, S., Mihara, K., et al. (2002). Mammalian mitochondrial endonuclease G. Digestion of R-loops and localization in intermembrane space. Eur. J. Biochem. 269, 5765-5770. doi: 10.1046/j.1432-1033.2002.03238.x
78. Ozeri-Galai, E., Lebofsky, R., Rahat, A., Bester, A. C., Bensimon, A., and Kerem, B. (2011). Failure of origin activation in response to fork stalling leads to chromosomal instability at fragile sites. Mol. Cell 43, 122-131. doi: 10.1016/j.molcel.2011.05.019
79. Pauklin, S., Sernández, I. V., Bachmann, G., Ramiro, A. R., and Petersen-Mahrt, S. K. (2009). Estrogen directly activates AID transcription and function. J. Exp. Med. 206, 99-111. doi: 10.1084/jem.20080521
80. Pavri, R., Gazumyan, A., Jankovic, M., Di Virgilio, M., Klein, I., Ansarah-Sobrinho, C., et al. (2010). Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 143, 122-133. doi: 10.1016/j.cell.2010.09.017
81. Ploski, J. E., and Aplan, P. D. (2001). Characterization of DNA fragmentation events caused by genotoxic and non-genotoxic agents. Mutat. Res. 473, 169-180. doi: 10.1016/S0027-5107(00)00147-0
82. Pombo-de-Oliveira, M. S., Koifman, S., and Brazilian Collaborative Study Group of Infant Acute Leukemia. (2006). Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol. Biomarkers Prev. 15, 2336-2341. doi: 10.1158/1055-9965.EPI-06-0031
83. Pullarkat, V., Slovak, M. L., Dagis, A., Bedell, V., Somlo, G., Nakamura, R., et al. (2009). Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation. Ann. Oncol. 20, 2000-2006. doi: 10.1093/annonc/mdp232
84. Quentin, S., Cuccuini, W., Ceccaldi, R., Nibourel, O., Pondarre, C., Pagès, M. P., et al. (2011). Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions. Blood 117, e161-e170. doi: 10.1182/blood-2010-09-308726
85. Reichel, M., Gillert, E., Angermüller, S., Hensel, J. P., Heidel, F., Lode, M., et al. (2001). Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene 20, 2900-2907. doi: 10.1038/sj.onc.1204401
86. Ruiz-Carrillo, A., and Renaud, J. (1987). Endonuclease G: a (dG)n X (dC)n-specific DNase from higher eukaryotes. EMBO J. 6, 401-407
87. Samejima, K., and Earnshaw, W. C. (2005). Trashing the genome: the role of nucleases during apoptosis. Nat. Rev. Mol. Cell Biol. 6, 677-688. doi: 10.1038/nrm1715
88. Scharf, S., Zech, J., Bursen, A., Schraets, D., Oliver, P. L., Kliem, S., et al. (2007). Transcription linked to recombination: a gene-internal promoter coincides with the recombination hot spot II of the human MLL gene. Oncogene 26, 1361-1371. doi: 10.1038/sj.onc.1209948
89. Schmiegelow, K., Lausten Thomsen, U., Baruchel, A., Pacheco, C. E., Pieters, R., Pombo-de-Oliveira, M. S., et al. (2012). High concordance of subtypes of childhood acute lymphoblastic leukemia within families: lessons from sibships with multiple cases of leukemia. Leukemia 26, 675-681. doi: 10.1038/leu.2011.274
90. Schnyder, S., Du, N. T., Le, H. B., Singh, S., Loredo, G. A., and Vaughan, A. T. (2009). Estrogen treatment induces MLL aberrations in human lymphoblastoid cells. Leuk. Res. 33, 1400-1404. doi: 10.1016/j.leukres.2009.01.023
91. Shim, H., Chi, H. S., Jang, S., Seo, E. J., Park, C. J., Lee, J. H., et al. (2010). Therapy-related acute leukemia in breast cancer patients: twelve cases treated with a topoisomerase inhibitor. Korean J. Hematol. 45, 177-182. doi: 10.5045/kjh.2010.45.3.177
92. Shimoni, A., Shem-Tov, N., Chetrit, A., Volchek, Y., Tallis, E., Avigdor, A., et al. (2013). Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced. Leukemia 27, 829-835. doi: 10.1038/leu.2012.299
93. Shivakumar, R., Tan, W., Wilding, G. E., Wang, E. S., and Wetzler, M. (2008). Biologic features and treatment outcome of secondary acute lymphoblastic leukemia-a review of 101 cases. Ann. Oncol. 19, 1634-1638. doi: 10.1093/annonc/mdn182
94. Sim, S. P., and Liu, L. F. (2001). Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis. J. Biol. Chem. 276, 31590-31595. doi: 10.1074/jbc.M103962200
95. So, C. W., Ma, Z. G., Price, C. M., Dong, S., Chen, S. J., Gu, L. J., et al. (1997). MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes. Cancer Res. 57, 117-122
96. Stanulla, M., Chhalliyil, P., Wang, J., Jani-Sait, S. N., and Aplan, P. D. (2001). Mechanisms of MLL gene rearrangement: site-specific DNA cleavage within the breakpoint cluster region is independent of chromosomal context. Hum. Mol. Genet. 10, 2481-2491. doi: 10.1093/hmg/10.22.2481
97. Stanulla, M., Wang, J., Chervinsky, D. S., Thandla, S., and Aplan, P. D. (1997). DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol. Cell. Biol. 17, 4070-4079
98. Storici, F., Bebenek, K., Kunkel, T. A., Gordenin, D. A., and Resnick, M. A. (2007). RNA-templated DNA repair. Nature 447, 338-341. doi: 10.1038/nature05720
99. Strick, R., Strissel, P. L., Borgers, S., Smith, S. L., and Rowley, J. D. (2000). Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. U.S.A. 97, 4790-4795. doi: 10.1073/pnas.070061297
100. Strick, R., Zhang, Y., Emmanuel, N., and Strissel, P. L. (2006). Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias. Hum. Genet. 119, 479-495. doi: 10.1007/s00439-006-0146-9
101. Strissel, P. L., Strick, R., Rowley, J. D., and Zeleznik-Le, N. J. (1998). An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood 92, 3793-3803
102. Strissel, P. L., Strick, R., Tomek, R. J., Roe, B. A., Rowley, J. D., and Zeleznik-Le, N. J. (2000). DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum. Mol. Genet. 9, 1671-1679. doi: 10.1093/hmg/9.11.1671
103. Strout, M. P., Marcucci, G., Bloomfield, C. D., and Caligiuri, M. A. (1998). The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc. Natl. Acad. Sci. U.S.A. 95, 2390-2395. doi: 10.1073/pnas.95.5.2390
104. Sugita, K., Taki, T., Hayashi, Y., Shimaoka, H., Kumazaki, H., Inoue, H., et al. (2000). MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia. Genes Chromosomes Cancer 27, 264-269. doi: 10.1002/(SICI)1098-2264(200003)27:3<264::AID-GCC6>3.0.CO;2-#
105. Sun, J., Oma, Y., Harata, M., Kono, K., Shima, H., Kinomura, A., et al. (2010). ATM modulates the loading of recombination proteins onto a chromosomal translocation breakpoint hotspot. PLoS ONE 5:e13554. doi: 10.1371/journal.pone.0013554
106. Székvölgyi, L., Hegedüs, E., Molnár, M., Bacsó, Z., Szarka, K., Beck, Z., et al. (2006). Nick-forming sequences may be involved in the organization of eukaryotic chromatin into approximately 50 kbp loops. Histochem. Cell Biol. 125, 63-73. doi: 10.1007/s00418-005-0073-1
107. Takeda, S., Liu, H., Sasagawa, S., Dong, Y., Trainor, P. A., Cheng, E. H., et al. (2013). HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma. J. Clin. Invest. 123, 3154-3165. doi: 10.1172/JCI65566
108. Tamai, H., Yamaguchi, H., Hamaguchi, H., Yagasaki, F., Bessho, M., Kobayashi, T., et al. (2008). Clinical features of adult acute leukemia with 11q23 abnormalities in Japan: a co-operative multicenter study. Int. J. Hematol. 87, 195-202. doi: 10.1007/s12185-008-0034-2
109. Tamaichi, H., Sato, M., Porter, A. C., Shimizu, T., Mizutani, S., and Takagi, M. (2013). Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor. Cancer Sci. 104, 178-184. doi: 10.1111/cas.12067
110. Thompson, L. H., and Hinz, J. M. (2009). Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights. Mutat. Res. 668, 54-72. doi: 10.1016/j.mrfmmm.2009.02.003
111. Trumpp, A., Essers, M., and Wilson, A. (2010). Awakening dormant haematopoietic stem cells. Nat. Rev. Immunol. 10, 201-209. doi: 10.1038/nri2726
112. Uckun, F. M., Herman-Hatten, K., Crotty, M. L., Sensel, M. G., Sather, H. N., Tuel-Ahlgren, L., et al. (1998). Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood 92, 810-821
113. Vanhees, K., de Bock, L., Godschalk, R. W., van Schooten, F. J., and van Waalwijk van Doorn-Khosrovani, S. B. (2011). Prenatal exposure to flavonoids: implication for cancer risk. Toxicol. Sci. 120, 59-67. doi: 10.1093/toxsci/kfq388
114. van Waalwijk van Doorn-Khosrovani, B. S., Janssen, J., Maas, L. M., Godschalk, R. W., Nijhuis, J. G., and van Schooten, F. J. (2007). Dietary flavonoids induce MLL translocations in primary human CD34+ cells. Carcinogenesis 28, 1703-1709. doi: 10.1093/carcin/bgm102
115. Vaughan, A. T., Betti, C. J., and Villalobos, M. J. (2002). Surviving apoptosis. Apoptosis 7, 173-177. doi: 10.1023/A:1014374717773
116. Walter, D., Lier, A., Geiselhart, A., Thalheimer, F. B., Huntscha, S., Sobotta, M. C., et al. (2015). Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature 520, 549-552. doi: 10.1038/nature14131
117. Wang, G., Gaddis, S., and Vasquez, K. M. (2013). Methods to detect replication-dependent and replication-independent DNA structure-induced genetic instability. Methods 64, 67-72. doi: 10.1016/j.ymeth.2013.08.004
118. Whitmarsh, R. J., Saginario, C., Zhuo, Y., Hilgenfeld, E., Rappaport, E. F., Megonigal, M. D., et al. (2003). Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing. Oncogene 22, 8448-8459. doi: 10.1038/sj.onc.1207052
119. Widlak, P., and Garrard, W. T. (2009). Roles of the major apoptotic nuclease-DNA fragmentation factor-in biology and disease. Cell. Mol. Life Sci. 66, 263-274. doi: 10.1007/s00018-008-8472-9
120. Wright, R. L., Slemmons, K. K., and Vaughan, A. T. (2014). Estradiol induces gene proximity and MLL-MLLT3 fusion in an AICDA-mediated pathway. Leuk. Lymphoma 17, 1-24. doi: 10.3109/10428194.2014.954112
121. Yahata, T., Takanashi, T., Muguruma, Y., Ibrahim, A. A., Matsuzawa, H., Uno, T., et al. (2011). Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells. Blood 118, 2941-2950. doi: 10.1182/blood-2011-01-330050
122. Zámecníkova, A. (2011). Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib. Hematol. Rep. 3:e13. doi: 10.4081/hr.2011.e13
123. Ziemin-van der Poel, S., McCabe, N. R., Gill, H. J., Espinosa, R. III, Patel, Y., Harden, A., et al. (1991). Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc. Natl. Acad. Sci. U.S.A. 88, 10735-10739. doi: 10.1073/pnas.88.23.10735